Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21755) 21755
Book Chapter (188) 188
Magazine Article (89) 89
Dissertation (44) 44
Publication (32) 32
Conference Proceeding (11) 11
Book / eBook (3) 3
Web Resource (3) 3
Newsletter (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18570) 18570
science & technology (10720) 10720
life sciences & biomedicine (10511) 10511
male (10106) 10106
female (9476) 9476
middle aged (8079) 8079
lymphoma, large b-cell, diffuse - pathology (7424) 7424
aged (6835) 6835
adult (6430) 6430
lymphoma, large b-cell, diffuse - drug therapy (4656) 4656
oncology (4351) 4351
hematology (3658) 3658
lymphoma, large b-cell, diffuse - diagnosis (3570) 3570
biological and medical sciences (3361) 3361
lymphoma (3327) 3327
prognosis (3260) 3260
medical sciences (3209) 3209
diffuse large b-cell lymphoma (3121) 3121
antineoplastic combined chemotherapy protocols - therapeutic use (2899) 2899
lymphoma, large b-cell, diffuse - genetics (2792) 2792
lymphomas (2611) 2611
abridged index medicus (2571) 2571
adolescent (2524) 2524
aged, 80 and over (2496) 2496
hematologic and hematopoietic diseases (2282) 2282
lymphoma, large b-cell, diffuse (2280) 2280
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (2187) 2187
treatment outcome (1902) 1902
lymphoma, large b-cell, diffuse - therapy (1877) 1877
pathology (1876) 1876
lymphoma, large b-cell, diffuse - metabolism (1870) 1870
lymphoma, large b-cell, diffuse - complications (1869) 1869
lymphoma, large b-cell, diffuse - mortality (1824) 1824
animals (1752) 1752
immunohistochemistry (1737) 1737
diagnosis, differential (1727) 1727
rituximab (1686) 1686
retrospective studies (1579) 1579
sarcoma (1558) 1558
chemotherapy (1536) 1536
child (1480) 1480
hemic and lymphatic diseases (1475) 1475
old medline (1467) 1467
cancer (1438) 1438
neoplasms (1425) 1425
lymphoma, non-hodgkin (1368) 1368
lymphoma, large b-cell, diffuse - immunology (1365) 1365
cyclophosphamide - administration & dosage (1305) 1305
young adult (1246) 1246
vincristine - administration & dosage (1245) 1245
lymphoma, large b-cell, diffuse - diagnostic imaging (1235) 1235
lymphoma, b-cell - pathology (1188) 1188
doxorubicin - administration & dosage (1187) 1187
biopsy (1109) 1109
neoplasm staging (1054) 1054
tumors (1028) 1028
cyclophosphamide - therapeutic use (1027) 1027
prednisone - administration & dosage (1025) 1025
antineoplastic combined chemotherapy protocols - administration & dosage (1008) 1008
mice (979) 979
disease-free survival (973) 973
vincristine - therapeutic use (946) 946
immune system diseases (922) 922
care and treatment (913) 913
prednisone - therapeutic use (895) 895
doxorubicin - therapeutic use (883) 883
survival rate (882) 882
lymphoma, non-hodgkin - pathology (862) 862
follow-up studies (852) 852
survival analysis (850) 850
antineoplastic agents - therapeutic use (836) 836
tomography, x-ray computed (832) 832
diffuse large b cell lymphoma (813) 813
medicine & public health (797) 797
b-cell lymphoma (796) 796
combined modality therapy (793) 793
analysis (783) 783
lymphoma, large b-cell, diffuse - radiotherapy (772) 772
child, preschool (756) 756
lymphoma, large b-cell, diffuse - surgery (729) 729
lymphocytes b (717) 717
non-hodgkin's lymphomas (715) 715
gene expression (711) 711
general & internal medicine (686) 686
immunophenotyping (680) 680
research (674) 674
medicine, general & internal (672) 672
antineoplastic agents (645) 645
fatal outcome (638) 638
diagnosis (637) 637
gene expression regulation, neoplastic (637) 637
lymph nodes - pathology (636) 636
time factors (635) 635
lymphoma, large b-cell, diffuse - etiology (634) 634
lymphoma, b-cell - genetics (632) 632
cell line, tumor (631) 631
remission induction (615) 615
risk factors (612) 612
lymphoma - pathology (609) 609
antibodies, monoclonal, murine-derived (606) 606
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18056) 18056
German (852) 852
Japanese (759) 759
French (724) 724
Italian (592) 592
Chinese (507) 507
Russian (495) 495
Spanish (309) 309
Polish (144) 144
Korean (86) 86
Portuguese (70) 70
Czech (55) 55
Romanian (54) 54
Hungarian (44) 44
Danish (36) 36
Dutch (29) 29
Turkish (19) 19
Serbian (16) 16
Bulgarian (15) 15
Croatian (13) 13
Hebrew (13) 13
Slovak (13) 13
Swedish (13) 13
Norwegian (11) 11
Finnish (9) 9
Ukrainian (3) 3
Afrikaans (2) 2
Bosnian (1) 1
Greek (1) 1
Indonesian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: A comprehensive review
by Camicia, Rosalba and Winkler, Hans C and Hassa, Paul O
Molecular cancer, ISSN 1476-4598, 12/2015, Volume 14, Issue 1, pp. 207 - 207
DLBCL | ABC-DLBCL | DTX3L | STAT1 | CAR-T cells | Chemoresistance | STAT3 | PARP | GCB-DLBCL | Antibody drug conjugate | BCR | NF-ΚB | Macrodomain | ADP-ribosylation | ARTD | Biochemistry & Molecular Biology | Oncology | Life Sciences & Biomedicine | Science & Technology | Animals | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Immunotherapy | Neoplasm Recurrence, Local - drug therapy | Drug Resistance, Neoplasm | Molecular Targeted Therapy | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Precision Medicine | Phosphates | Ubiquitin | Biological products | Genes | Mortality | Development and progression | Non-Hodgkin's lymphomas | B cells | Transforming growth factors | Gene expression | T cells | Chemotherapy | Ligases | Health aspects | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Higher response to lenalidomide in relapsed/refractory diffuse large B‐cell lymphoma in nongerminal center B‐cell–like than in germinal center B‐cell–like phenotype
by Hernandez‐Ilizaliturri, Francisco J and Deeb, George and Zinzani, Pier L and Pileri, Stefano A and Malik, Farhana and Macon, William R and Goy, Andre and Witzig, Thomas E and Czuczman, Myron S
Cancer, ISSN 0008-543X, 11/2011, Volume 117, Issue 22, pp. 5058 - 5066
nongerminal center B‐cell–like lymphoma | relapsed/refractory | lenalidomide | Hans algorithm | diffuse large B‐cell lymphoma | germinal center B‐cell–like lymphoma | germinal center B-cell-like lymphoma | diffuse large B-cell lymphoma | nongerminal center B-cell-like lymphoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Recurrence | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prognosis | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Germinal Center - pathology | Thalidomide - administration & dosage | Disease-Free Survival | Thalidomide - analogs & derivatives | Lymphoma, Large B-Cell, Diffuse - classification | Female | Aged | Thalidomide - therapeutic use | Care and treatment | Lymphomas | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma
by Cardenas, Mariano G and Yu, Wenbo and Beguelin, Wendy and Teater, Matthew R and Geng, Huimin and Goldstein, Rebecca L and Oswald, Erin and Hatzi, Katerina and Yang, Shao-Ning and Cohen, Joanna and Shaknovich, Rita and Vanommeslaeghe, Kenno and Cheng, Huimin and Liang, Dongdong and Cho, Hyo Je and Abbott, Joshua and Tam, Wayne and Du, Wei and Leonard, John P and Elemento, Olivier and Cerchietti, Leandro and Cierpicki, Tomasz and Xue, Fengtian and MacKerell, Alexander D and Melnick, Ari M
The Journal of clinical investigation, ISSN 0021-9738, 09/2016, Volume 126, Issue 9, pp. 3351 - 3362
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Neoplasm Transplantation | Proto-Oncogene Proteins c-bcl-6 - antagonists & inhibitors | Translocation, Genetic | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Magnetic Resonance Spectroscopy | Humans | Gene Expression Regulation, Neoplastic | Male | Mice, SCID | Animals | Proto-Oncogene Proteins c-bcl-6 - metabolism | Drug Design | HEK293 Cells | Cell Line, Tumor | Protein Binding | Indoles - pharmacology | Ligands | Antineoplastic Agents - pharmacology | Mice | Thiazolidinediones - pharmacology | Doxorubicin - pharmacology | Drug Screening Assays, Antitumor | Physiological aspects | Care and treatment | Usage | Lymphomas | Enzyme inhibitors | B cells | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights